Position in CGC
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$53,858
-$4,772,480 QoQ
Shares Held
56,753
-98.7% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in CGC Over Time
Shares Held
Position Value (USD)
Derivatives in CGC
reported options exposure · as of Mar 31, 2026CallValue
$460,265
CallShares
485,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. CGC ranks #41 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
99,106 | $58,767,875 | |
| 2 | VTRS |
Viatris Inc
|
3,882,541 | $52,453,128 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
2,602,543 | $48,199,096 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
959,257 | $46,188,223 | |
| 5 | XERS |
Xeris Biopharma Holdings, Inc.
|
7,788,811 | $45,175,103 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
1,982,724 | $44,809,561 | |
| 7 | LQDA |
Liquidia Corp
|
873,065 | $32,949,472 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
622,450 | $32,174,439 |
All Filings in CGC
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $460,265 | 485,000 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $53,858 | 56,753 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,826,338 | 4,233,630 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $859,218 | 753,700 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $1,100,402 | 753,700 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $2,718,795 | 1,862,189 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $327,814 | 268,700 | Call | Defined | 2025-08-14 | |
| 2025-03-31 | $453,817 | 498,700 | Call | Defined | 2025-05-15 | |
| 2025-03-31 | $146,456 | 160,941 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,407,638 | 878,700 | Call | Defined | 2025-02-14 | |
| 2024-12-31 | $1,307,092 | 477,041 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $315,261 | 65,407 | Shares | Defined | 2024-11-14 | |
| 2024-09-30 | $3,547,520 | 736,000 | Call | Defined | 2024-11-14 | |
| 2024-06-30 | $93,376 | 14,477 | Shares | Defined | 2024-08-14 | |
| 2024-06-30 | $1,032,000 | 160,000 | Put | Defined | 2024-08-14 | |
| 2024-06-30 | $4,224,750 | 655,000 | Call | Defined | 2024-08-14 | |
| 2024-03-31 | $776,786 | 90,010 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $87,590 | 17,141 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||